1. Burkhart CG: Scabies: An epidemiologic reassessment. Ann Intern Med 98:498-503, 1983
2. Mellanby K: Scabies, 2nd edition. Hampton, England, E.W. Classey Ltd, 1972
3. Carslow RW, Dobson RM, Hook AJK: Mites in the environment of cases of Norwegian scabies. Br J Dermatol 92:333-337, 1975
4. Estes SA, Arlian L: Survival of Sarcoptes scabiei. J Am Acad Dermatol 5:343-345, 1981
5. Arlian LG, Estes SA, Vyszenski-Moher DL: Prevalence of Sarcoptes scabiei in the environment of scabietic patients. J Am Acad Dermatol 21:806-811, 1988
6. Arlian LG, Runyan RA, Achar S: Survival and infestivity of Sarcoptes scabiei var canis and var hominis. J Am Acad Dermatol 11:210-215, 1984
7. Burgess I: Sarcoptes scabiei and scabies. Adv Parsitol 33:235-293, 1994
8. Fimiani M et al: The behaviour of Sarcoptes scabiei in the skin. J Invest Dermatol 107:659, 1996
9. Bergstrom FC et al: Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol 182:7809-7817, 2009
10. Prins C, Stucki L, French L: Dermoscopy for the in vivo detection of Sarcoptes scabiei. Dermatology 208:241-243, 2004
11. Argenziano G, Fabbrocini G, Delfino M: Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol 133:751-753, 1997
12. van der Heijden HM, Rambags PG, Elbers AR: Validation of ELISAs for the detection of antibodies to Sarcoptes scabiei in pigs. Vet Parasitol 89:95-107, 2000
13. Wong MM et al: The presence of cutaneous antibodies in scabies. J Invest Dermatol 129:S17, 2009
14. Bornhovd E et al: Bullous scabies and scabies-triggered bullous pemphigoid. Hautarzt 52:56-61, 2001
15. Anonymous: Labeling changes for
Lindane.
FDA Consum 37:6, 2003
16. DA Public Health Advisory:
Safety of Topical Lindane Products for the Treatment of Scabies and Lice. Center for Drug Evaluation and Research, http://www.fda.gov/cder/drug/infopage/
lindane/default.htm, accessed Jun 5,2003
17. California Department of Health Services: State Health Director Offers Tips for Protecting Children From Head Lice. Sacramento, California Dept of Health Services; Oct 10, 2000. News Release No. 54-00
18. Burkhart CG, Burkhart CN: Safety and efficacy of pediculicides for head lice. Expert Opin Drug Saf 5:169-176, 2006
19. Pasay C et al: The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides. PLoS Negl Trop Dis 3:e354, 2009
20. Pruksachatkunakorn C, Damrongsak M, Sinthupuan S: Sulfur for scabies outbreaks in orphanages. Pediatr Dermatol 19:448-453, 2002
21. Diaz M, Cazorla D, Acosta M: Efficacy, safety, and acceptability of precipitated sulphur petrolatum for topical treatment of scabies at the city of Coro, Falcon State, Venezuela. Rev Invest Clin 56:615-622, 2004
22. Campbell WC:
Ivermectin and Abamectin. New York, Springer-Verlag, 1989, pp. 149-161, 215-229
23. Burkhart CN:
Ivermectin: An assessment of its pharmacology, microbiology, and safety.
Vet Human Toxicol 42:30-35, 2000
24. Meinking TL, Taplin D, Hermida JL: The treatment of scabies with
ivermectin.
N Engl J Med 333:26-30, 1996
25. Aubin F, Humbert P:
Ivermectin for crusted (Norwegian) scabies.
N Engl J Med 332:1995, 1995
26. Marty P, Gari-Toussaint M, LeFichoux Y: Efficacy of
ivermectin in the treatment of an epidemic of Sarcoptes scabiei.
Ann Trop Med Parasitol 88:433, 1994
27. Grob M, Dorn K, Lautenschlager S: Grain mites: A small epidemic caused by Pyemotes species. Hautarzt 49:838-843, 1998
28. Kunkle GA, Greiner
EC: Dermatitis in horses and man caused by the straw itch mite.
J Am Vet Med Assoc 181:467-469, 1982
29. Elston DM: What's eating you? Chiggers. Cutis 77:350-352, 2006
30. Jeong SK, Kim HJ, Youm JK: Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 128:1930-1939, 2008
31. Bussmann C et al: Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 118:1292-1298, 2006
32. Mumcuoglu KY, Klaus S, Kafka D: Clinical observation related to head lice infestation. J Am Acad Dermatol 25:248-251, 1991
33. Carter D: 1990 Insect egg glue. Ph.D. Thesis, Department of Applied Biology, Cambridge University
34. Burkhart CN: Fomite transmission with head lice: A continuing controversy. Lancet 361:99-100, 2003
35. Takano-Lee M et al: Transmission potential of the human head louse, Pediculus capitis. Int J Dermatol 44:811-816, 2005
36. Burkhart CN, Burkhart CG: Fomite transmission in head lice. J Am Acad Dermatol 56:1044-1047, 2007
37. Burgess IF: Human lice and their management. Adv Parasitol 36:271-342, 1995
38. Mauder JW: An update on head lice. Health Visit 66:317-318, 1993
39. Speare R, Cahill C, Thomas G: Head lice on pillows, and strategies to make a small risk even less. Int J Dermatol 42:626-629, 2003
40. Burkhart CN et al: Molecular composition of the louse sheath. J Parasitol 85:559-561, 1999
41. Burkhart CN: Nit Sheath and Bacterial Symbiotes of the Human Head Louse (Pediculus Humanus Capitis) [Master's Thesis]. Toledo, OH, Medical College of Ohio, 2003
42. Burkhart CN, Burkhart CG, Pchalak I: The adherent cylindrical nit structure and its chemical denaturation in vitro: An assessment with therapeutic implication for head lice. Arch Pediatr Adoles Med 1152:711-712, 1998
43. Dodd C: Treatment of head lice: Choice of treatment will depend on local patterns of resistance. BMJ 323(7321):1084, 2001
44. Roberts RJ et al: Comparison of wet combing with
malathion for treatment of head lice in the UK: A pragmatic randomized controlled trial.
Lancet 356:540-544, 2000
45. Jahnke C et al: Accuracy of diagnosis of pediculosis capitis: Visual inspection vs wet combing. Arch Dermatol 145:309-313, 2009
46. Fournier A: Human pathogens in body and head lice. Emerg Infect Dis 8:1515-1518, 2002
47. Robinson B: Potential role of head lice, Pediculus humanus capitis, as vectors of Rickettsia prowazekii. Parasitol Res 90:209-211, 2003
48. Weyer KF: Biological relationships between lice and microbial agents. Annu Rev Entomol 5:405-420, 1960
49. Frankowski BL, Weiner LB, Committee on School Health the Committee on Infectious Diseases. American Academy of Pediatrics: Head Lice. Pediatrics 110(3):638-643, 2002
50. Grayson ML: The treatment triangle for staphylococcal infections. N Engl J Med 355(7):724-727, 2006
51. Meinking TL et al: Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol 138:220-224, 2002
52. Meinking TL et al: Comparative efficacy of treatments for pediculosis capitis infestations. Arch Dermatol 122:267-271, 1986
53. Meinking TL, Entzel P, Villar ME: Comparative efficacy of treatments for pediculosis capitis infestations: Update 2000. Arch Dermatol 137(3):287-292, 2001
54. Downs AMR, Stafford KA, Hunt LP: Widespread insecticide resistance in head lice to the over-the-counter pediculicides in England and the emergence of carbaryl resistance. Br J Dermatol 146:88-89, 2002
55. Burkhart CN, Burkhart CG: Topical pyrethroids: Assessment of function and efficacy in head lice. Int J Pediatr 17:209-212, 2002
56. Chosidow O, Chastang C, Brue C: Controlled study of
malathion and d-phenothrin lotions for
Pediculus humanus var
capitis-infested school children.
Lancet 344:1724-1727, 1994
57. Meinking TL, Serrano L, Hard B: Comparative in vitro pediculocidal efficacy of treatments in a resistant head lice population. Arch Dermatol 138:220-224, 2002
58. Meinking TL et al: Efficacy of a reduced application time of Ovide lotion (0.5%
malathion) compared to Nix crème rinse (1%
permethrin) for the treatment of head lice.
Ped Dermatol 21:670-674, 2004
59. Burgess IF, Brown CM, Peck S: Head lice resistant to pyrethroid insecticides in Britain. Br Med J 311:752, 1995
60. Downs AMR, Stafford KA, Coles GC: Head lice: Prevalence in school children and insecticide resistance. Parasitol Today 15:1-5, 1999
61. Bailey AM, Procive P: Persistent head lice following multiple treatments: Evidence for insecticide resistance in Pediculus humanus capitis. Australas J Dermatol 42:146-149, 2001
62. Downs AMR, Stafford KA, Hunt LP: Widespread insecticide resistance in head lice to the over-the-counter pediculicides in England and the emergence of carbaryl resistance. Br J Dermatol 146:88-89, 2002
63. Mumcuoglu KY, Hemingway J, Miller J:
Permethrin resistance in the head louse Pediculus capitis from Israel.
Med Vet Entolmol 9:427-432, 1995
64. Rupes V, Moravek J, Shmela J: A resistance of head lice, Pediculus capitis, to
permethrin in the Czech Republic.
Cent Eur J Pub Health 3:30-32, 1995
65. Yoon YS et al: Resistance and cross-resistance to insecticides in human head lice from Florida and California. Pestic Biochem Physiol 80:192-201, 2004
66. Chosidow O et al: Oral
ivermectin versus
malathion lotion for difficult-to-treat head lice.
N Engl J Med 362:896-905, 2010
67. Burkhart CN, Burkhart CG: Recommendation to standardize pediculicidal and ovicidal testing for head lice (Anoplura: Pediculidae). J Med Entomol 38(2):127-129, 2001
68. Burkhart CG, Burkhart CN: Asphyxiation of lice with topical agents, not a reality …yet. J Am Acad Dermatol 54:721-722, 2006
69. Narahashi T: Neuronal ion channels as the target sites of insecticides. Pharmacol Toxicol 79:1-14, 1996
70. Adams ME, Miller TA: Neural and behavioral correlates of pyrethroid and DDT type poisoning in the house fly Musca domestica. Pestic Biochem Physiol 13:137-147, 1980
71. World Health Organization. Instructions for determining the susceptibility or resistance of body lice and head lice to insecticides. WHO/VBC 81:808, 1981
72. Sasaki T et al: First molecular evidence of Bartonella quintana in Pediculus humanus capitis (Phthiraptera: Pediculidae) collected from Nepalese children. J Med Entomol 43:110-112, 2006
73. Bonilla DL et al: Bartonella quintana in body lice and head lice from homeless persons, San Francisco, California, USA. Emerg Infect Dis 15:912-915, 2009
74. Fang R, Houhamdi L, Raoult D: Detection of Rickettsia prowazekii in body lice and their feces by using monoclonal antibodies. J Clin Microbiol 40:3358-3363, 2002
75. Houhamdi L et al: An experimental model of human body louse infection with Rickettsia prowazekii. J Infect Dis 186:1639-1646, 2002
76. Raoult D, Roux V: The body louse as a vector of reemerging human diseases. Clin Infect Dis 29:888-911, 1999
77. Alcantara V et al: Molecular detection of Bartonella quintana in human body lice from Mexico City. Clin Microbiol Infect 15:93-94, 2009
78. Burkhart CG, Burkhart CN: Oral
ivermectin for
Phthirus pubis.
J Am Acad Dermatol 51:1038, 2004
79. Kalter DC, Sperber J, Rosen T: Treatment of pediculosis pubis: clinical comparison of efficacy and tolerance of 1%
lindane shampoo vs. 1%
permethrin crème rinse.
Arch Dermatol 123:1315-1319, 1987
80. Speare R, Koehler JM: A case of pubic lice resistant to pyrethrins. Aust Fam Physician 30:572-574, 2001
81. Burkhart CG, Burkhart CN: Oral
ivermectin therapy for
Phthiriasis palpebrarum.
Arch Ophthal 118:134-135, 2000